Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats

被引:140
作者
Nimmo, AJ
Cernak, I
Heath, DL
Hu, X
Bennett, CJ
Vink, R [1 ]
机构
[1] Georgetown Univ, Dept Neurosci, Washington, DC 20007 USA
[2] James Cook Univ N Queensland, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia
[3] Univ Adelaide, Dept Pathol, Adelaide, SA 5005, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
neurotrauma; capsaicin; diffuse brain injury; edema; magnesium; neuropeptides;
D O I
10.1016/j.npep.2003.12.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study has used capsaicin-induced neuropeptide depletion to examine the role of neurogenic inflammation in the development of edema and functional deficits following traumatic brain injury (TBI). Adult, male rats were treated with capsaicin (neuropeptide-depleted) or equal volume vehicle (controls) 14 days prior to induction of moderate/severe diffuse TBI. Injury in vehicle treated control animals resulted in acute (4-5 h) edema formation, which was confirmed as being vasogenic in origin by diffusion weighted magnetic resonance imaging and the presence of increased permeability of the blood-brain barrier (BBB) to Evans blue dye. There was also a significant decline in brain magnesium concentration, as assessed by phosphorus magnetic resonance spectroscopy, and the development of profound motor and cognitive deficits. In contrast, capsaicin pre-treatment resulted in a significant reduction in post-traumatic edema formation (p < 0.001), BBB permeability (p < 0.001), free magnesium decline (p < 0.01) and both motor and cognitive deficits (p < 0.001). We conclude that neurogenic inflammation may play an integral role in the development of edema and functional deficits following TBI, and that neuropeptides may be a novel target for development of interventional pharmacological strategies. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:40 / 47
页数:8
相关论文
共 41 条
  • [11] NEUROPHARMACOLOGICAL MECHANISMS OF CAPSAICIN AND RELATED SUBSTANCES
    DRAY, A
    [J]. BIOCHEMICAL PHARMACOLOGY, 1992, 44 (04) : 611 - 615
  • [12] NEUROPEPTIDES AND CENTRAL-NERVOUS-SYSTEM INJURY - CLINICAL IMPLICATIONS
    FADEN, AI
    [J]. ARCHIVES OF NEUROLOGY, 1986, 43 (05) : 501 - 504
  • [13] Severe head injury in children: Impact of risk factors on outcome
    Feickert, HJ
    Drommer, S
    Heyer, R
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1999, 47 (01): : 33 - 38
  • [14] A NEW MODEL OF DIFFUSE BRAIN INJURY IN RATS .2. MORPHOLOGICAL CHARACTERIZATION
    FODA, MAA
    MARMAROU, A
    [J]. JOURNAL OF NEUROSURGERY, 1994, 80 (02) : 301 - 313
  • [15] Effect of traumatic brain injury on mouse spatial and nonspatial learning in the Barnes circular maze
    Fox, GB
    Fan, L
    LeVasseur, RA
    Faden, AI
    [J]. JOURNAL OF NEUROTRAUMA, 1998, 15 (12) : 1037 - 1046
  • [16] INTRATHECAL SOMATOSTATIN, SOMATOSTATIN ANALOGS, SUBSTANCE-P ANALOG AND DYNORPHIN-A CAUSE COMPARABLE NEUROTOXICITY IN RATS
    GAUMANN, DM
    GRABOW, TS
    YAKSH, TL
    CASEY, SJ
    RODRIGUEZ, M
    [J]. NEUROSCIENCE, 1990, 39 (03) : 761 - 774
  • [17] Tachykinin receptor (NK1, NK2, NK3) binding sites in the rat caudal brainstem following neonatal capsaicin administration
    Geraghty, DP
    Mazzone, SB
    [J]. BRAIN RESEARCH, 2003, 979 (1-2) : 230 - 234
  • [18] THE ROTAROD TEST - AN EVALUATION OF ITS EFFECTIVENESS IN ASSESSING MOTOR DEFICITS FOLLOWING TRAUMATIC BRAIN INJURY
    HAMM, RJ
    PIKE, BR
    ODELL, DM
    LYETH, BG
    JENKINS, LW
    [J]. JOURNAL OF NEUROTRAUMA, 1994, 11 (02) : 187 - 196
  • [19] HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843
  • [20] Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311